8th Jan 2020 11:25
(Alliance News) - Renalytix AI PLC on Wednesday said it has received a laboratory improvement amendments certificate for its newly-established laboratory in Salt Lake City, Utah.
The Salt Lake City facility is expected to begin operating in the second quarter of 2020.
The AIM-listed clinical diagnostics company said the laboratory will help the company's 2020 strategy, including the scaling-up of test volumes, optimising sample processing costs, and accelerating payer coverage determinations.
A primary benefit of the new Salt Lake City laboratory, in combination with a New York City facility, is to enable a five-fold increase in maximum potential processing capacity to 15,000 reportable test results per month, Renalytix explained.
The issue of certificate also allows the company to apply for local coverage determination from Noridian Healthcare Solutions, which will result in payments to Renalytix AI for KidneyIntelX tests run in the Utah laboratory on patient samples received from all 50 US states.
Renalytix shares were trading 2.2% lower in London on Wednesday at 352.90 pence each.
By Evelina Grecenko; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Renalytix Plc